McCormick & Company
MKC
$50.92
-3.65%
McCormick & Company is the world's leading manufacturer of spices, herbs, seasonings, and flavorings, operating in the packaged foods industry. Its portfolio includes iconic brands such as Old Bay, Frank's RedHot, French's, and Cholula, making it a dominant player in both consumer and foodservice channels. The current investor narrative centers on McCormick's transformative $45 billion acquisition of Unilever's food business, which would add Knorr and Hellmann's to its portfolio, creating a $20 billion flavor giant. While the deal promises significant scale and cost synergies, it also introduces integration risks, debt, and dilution, fueling a sharp debate between value investors and skeptics.…
MKC
McCormick & Company
$50.92
Related headlines
MKC 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on McCormick & Company's 12-month outlook, with a consensus price target around $60.23 and implied upside of +18.3% versus the current price.
Average Target
$60.23
0 analysts
Implied Upside
+18.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$51 - $75
Analyst target range
McCormick is covered by 4 analysts, with a consensus leaning bullish: 2 Buy ratings (Deutsche Bank, TD Cowen), 1 Outperform (Bernstein), 1 Overweight (JP Morgan), and 2 Neutral/Equal Weight (Barclays, UBS). The average estimated EPS for the next fiscal year is $4.63, with a low of $4.56 and high of $4.70. The average revenue estimate is $8.84 billion, implying a forward P/E of 15.41x based on the current price of $50.92. The implied upside to the average target is not directly provided, but based on the forward P/E of 15.41x and industry average of 20x, the stock could be undervalued by ~30% if it re-rates.
The target range is not explicitly given, but the EPS estimates suggest a range of $4.56 to $4.70, implying a price range of roughly $70 to $72 using a 15x multiple. The high target assumes successful integration of the Unilever deal, margin expansion, and multiple expansion back to historical levels. The low target prices in execution risk, higher debt costs, and potential earnings dilution. Recent ratings have been stable, with no downgrades, but the wide spread in analyst opinions (from Neutral to Overweight) reflects high uncertainty. The limited coverage (4 analysts) is typical for a mid-cap stock, but the high institutional interest (JP Morgan, Barclays, etc.) suggests the stock is well-followed. The consensus is cautiously optimistic, but the lack of a strong buy signal indicates the market is waiting for clearer signs of deal success.
Drowning in data?
Find the real signal!
Bulls vs Bears: MKC Investment Factors
McCormick presents a high-conviction but high-risk investment case centered on the transformative $45B Unilever acquisition. On the bull side, the deal promises massive scale, cost synergies, and a forward P/E of 15.41x that is a 23% discount to the industry average, suggesting significant upside if execution succeeds. On the bear side, the acquisition introduces substantial debt, dilution, and integration risks, with net margin already compressing to 8.27% and the stock down 28% over the past year. The single most important tension is whether management can successfully integrate Unilever's food brands and realize the projected synergies without derailing the core business. Currently, the bear case has stronger evidence given the stock's 41% drawdown from its peak and the market's deep skepticism, but the bull case offers asymmetric upside if the deal delivers. The debate hinges on execution: if integration goes smoothly, the stock could re-rate to historical multiples; if not, further downside to the 52-week low or below is possible.
Bullish
- Transformative Unilever acquisition: The $45B acquisition of Unilever's food business will nearly double revenue and create a $20B flavor giant, with significant cost synergies and scale benefits. The combined entity is expected to generate 70% of sales from consumers and 30% from foodservice, with 40% from faster-growing emerging markets.
- Attractive forward valuation: The forward P/E of 15.41x is a 23% discount to the packaged foods industry average of ~20x, and well below McCormick's 5-year historical P/E range of 20-35x. This implies the market is pricing in significant execution risk, offering a potential value opportunity if the deal succeeds.
- Accelerating revenue growth: Q2 2026 revenue grew 16.7% YoY to $1.937B, up from $1.660B in Q2 2025, driven by pricing and volume recovery. The multi-quarter trend shows acceleration from 2.9% YoY growth in Q4 2025 to 16.7% in Q1 and Q2 2026.
- Strong free cash flow generation: TTM free cash flow is $1.158B, providing a cushion for debt servicing and integration costs. Operating cash flow of $379.8M in Q2 2026 comfortably covers capex of $42.7M, indicating a cash-generative core business.
Bearish
- Massive debt and dilution risk: The $45B Unilever acquisition will significantly increase debt from the current debt-to-equity ratio of 0.70, likely pushing leverage to uncomfortable levels. The deal also introduces dilution risk, as financing may require equity issuance, and interest expenses have already risen to $62.7M in Q2 2026 from $51M a year ago.
- Integration and execution risk: Merging Unilever's food brands (Knorr, Hellmann's) into McCormick's operations is a complex undertaking. The stock has already fallen 28% over the past year and hit a 52-week low of $44.82, reflecting deep investor skepticism about management's ability to execute the deal successfully.
- Margin compression from deal costs: Net margin compressed to 8.27% in Q2 2026 from 10.55% a year ago, and operating margin fell to 14.27% from 14.81%. These declines are attributed to higher interest expenses and integration costs, which could persist for several quarters.
- Premium valuation on EV basis: EV/EBITDA of 16.21x is well above the packaged foods industry median of ~12x, indicating a premium on an enterprise basis. This leaves little room for error; any misstep in the acquisition could lead to multiple compression and further downside.
MKC Technical Analysis
McCormick is in a sustained downtrend, with a 1-year price change of -28.03% and the stock currently trading at $50.92, just 22% above its 52-week low of $44.82 and 31% below the 52-week high of $73.84. This positioning near the low end of the range suggests the market is pricing in significant pessimism, but also raises the possibility of a value opportunity if the fundamental thesis holds. The stock's beta of 0.626 indicates it is less volatile than the broader market, which may appeal to defensive investors but also means it has not participated in the SPY's 21.32% 1-year gain.
Short-term momentum shows a mixed picture: the 1-month price change is +6.37%, indicating a recent bounce, while the 3-month change is -4.41%, still negative. This divergence suggests the stock may be attempting to stabilize after a steep decline, but the longer-term downtrend (6-month change of -24.05%) remains intact. The relative strength versus the S&P 500 is deeply negative across all periods, with a 1-year relative strength of -49.35%, confirming persistent underperformance. The recent volume spike around the Unilever deal announcement could signal institutional accumulation or distribution.
Key support lies at the 52-week low of $44.82, a break below which would likely trigger further selling and test the next major support level. Resistance is at the 52-week high of $73.84, and a breakout above that would signal a trend reversal. The stock's beta of 0.626 implies it is 37.4% less volatile than the market, meaning it tends to decline less in downturns but also lag in rallies. This lower volatility profile is consistent with a defensive staple stock, but the current drawdown of -41.21% from its peak is unusually severe for such a low-beta name.
Beta
0.63
0.63x market volatility
Max Drawdown
-41.2%
Largest decline past year
52-Week Range
$45-$74
Price range past year
Annual Return
-28.0%
Cumulative gain past year
| Period | MKC Return | S&P 500 |
|---|---|---|
| 1m | +6.4% | +0.6% |
| 3m | -4.4% | +6.3% |
| 6m | -24.0% | +9.1% |
| 1y | -28.0% | +20.9% |
| ytd | -24.3% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MKC Fundamental Analysis
McCormick's revenue trajectory is accelerating, with Q2 2026 revenue of $1.937 billion growing 16.7% year-over-year, up from $1.660 billion in Q2 2025. This growth is driven by the Consumer segment ($1.143 billion) and Flavor Solutions ($794 million), with the pending Unilever acquisition expected to nearly double revenue. However, the multi-quarter trend shows revenue growth has been volatile: Q1 2026 saw $1.874 billion (up 16.7% YoY), while Q4 2025 was $1.850 billion (up 2.9% YoY). The acceleration in recent quarters is partly due to pricing and volume recovery, but the base effect from the Unilever deal will dramatically reshape the top line.
The company is profitable, with Q2 2026 net income of $160.2 million and a gross margin of 40.18%, which is above the 37.9% trailing gross margin. However, net margin has compressed to 8.27% in Q2 2026 from 10.55% in Q2 2025, reflecting higher interest expenses and integration costs. Operating margin was 14.27% in Q2 2026, down from 14.81% a year ago, indicating margin pressure from the deal. The industry average gross margin for packaged foods is around 35-40%, so McCormick's margins are competitive but not exceptional.
McCormick's balance sheet shows a debt-to-equity ratio of 0.70, which is manageable but will increase significantly with the $45 billion Unilever acquisition. Free cash flow (TTM) is $1.158 billion, providing some cushion, but the current ratio of 0.70 indicates tight liquidity. ROE is 13.76%, decent for a consumer staple, but ROA is only 5.14%, reflecting the capital-intensive nature of the business. The company generated $379.8 million in operating cash flow in Q2 2026, enough to cover capital expenditures of $42.7 million, but the upcoming deal will likely require external financing, increasing financial risk.
Quarterly Revenue
$1.9B
2026-05
Revenue YoY Growth
+16.7%
YoY Comparison
Gross Margin
40.2%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MKC Overvalued?
Since net income is positive ($160.2 million in Q2 2026), we lead with the P/E ratio. The trailing P/E is 22.59x, while the forward P/E is 15.41x, implying the market expects earnings to grow significantly—likely due to the Unilever acquisition. The gap between trailing and forward P/E suggests the market is pricing in a substantial earnings boost from the deal, but also reflects the recent earnings dip from integration costs. The P/E of 22.59x is above the S&P 500 average of ~20x, but the forward multiple of 15.41x is more attractive.
Compared to the packaged foods industry average P/E of approximately 20x, McCormick's trailing P/E of 22.59x represents a 13% premium. However, its forward P/E of 15.41x is a 23% discount to the industry forward average of ~20x, suggesting the market is pricing in a recovery. The EV/EBITDA of 16.21x is also above the industry median of ~12x, indicating a premium on an enterprise basis. This premium may be justified by McCormick's strong brand portfolio and the potential synergies from the Unilever deal, but it also leaves little room for error.
Historically, McCormick's trailing P/E has ranged from 20x to 35x over the past five years, with the current 22.59x near the lower end of that range. The P/B ratio of 3.11x is also below the 5-year average of ~4.5x, suggesting the stock is trading at a discount to its historical book value multiple. This could indicate a value opportunity if the Unilever deal succeeds, but it also reflects the market's skepticism about the acquisition's execution. The PEG ratio is not available, but the forward P/E discount to historical levels implies the market is not fully pricing in the growth potential.
PE
22.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 20x~41x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: McCormick's balance sheet is manageable with a debt-to-equity ratio of 0.70, but the $45B Unilever acquisition will dramatically increase leverage, likely pushing debt-to-equity above 2.0x. Interest expenses have already risen to $62.7M in Q2 2026 from $51M a year ago, and net margin has compressed to 8.27% from 10.55%. The current ratio of 0.70 indicates tight liquidity, and the company may need to issue equity or take on additional debt to finance the deal, diluting existing shareholders. Free cash flow of $1.158B provides some cushion, but integration costs could pressure cash flows for several quarters.
Market & Competitive Risks: The stock's EV/EBITDA of 16.21x is a 35% premium to the industry median of ~12x, making it vulnerable to multiple compression if the deal falters. With a beta of 0.626, McCormick is less correlated to the market, but its 1-year relative strength of -49.35% versus the S&P 500 indicates persistent underperformance. The packaged foods sector faces headwinds from private label competition and input cost inflation, and the Unilever deal could distract management from core operations. Recent news highlights that investors view the acquisition as risky, with Motley Fool calling it 'most risky' among recent M&A deals.
Worst-Case Scenario: If the Unilever acquisition fails to deliver expected synergies, debt costs spiral, or integration disrupts operations, the stock could fall to its 52-week low of $44.82 or below. From the current price of $50.92, this represents a downside of -12%. However, if the deal collapses or earnings deteriorate significantly, the stock could test the $40 level, implying a -21% loss. The historical max drawdown of -41.21% from the peak of $73.84 to the low of $44.82 has already occurred, but further downside is possible if the market loses confidence in the deal's viability.
